Skip to content
dAb ImmunoTech

Solutions For Immunoassays and In Vitro Immunodiagnostics

  • Home
  • Company
    • Overview
    • Mission
    • Partnership
  • COVID-19
    • Lateral Flow
    • ELISA
    • Reagents
  • Services
  • Support
    • Documents
      • Brochure
      • Flyer
      • Manual
      • Mini Manual
      • Protocol
      • LFU
      • Fact for Providers
      • Fact for Patients
      • Assay Map
    • FAQs
    • Feedback
    • Resources
    • Abbreviations
  • News
  • Contact
News
May 28, 2020 Sue Zhang

FDA has acknowledged receipt of the request and assigned an EUA number On May 16, 2020

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has acknowledged receipt and processing

Read More
News
May 14, 2020 Sue Zhang

FDA has acknowledged receipt of the request and assigned a pre-EUA number On May 7, 2020

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has acknowledge receipt and processing

Read More
News
April 15, 2020 Robbie Hay

dAb ImmunoTech Announced Development of SARS-CoV-2 (COVID-19) IgG and IgM Dual Antibody Test

dAb ImmunoTech, Inc., a novel near Atlanta, GA based immuno-diagnostic company focused on the development of rapid testing solutions for

Read More
News
April 10, 2020 Robbie Hay

Coronavirus Disease (COVID-19) Updates

Get updates at this link:https://ncov2019.live

Read More

Shopping cart

Latest news

  • FDA has acknowledged receipt of the request and assigned an EUA number On May 16, 2020
  • FDA has acknowledged receipt of the request and assigned a pre-EUA number On May 7, 2020
  • dAb ImmunoTech Announced Development of SARS-CoV-2 (COVID-19) IgG and IgM Dual Antibody Test

Upcoming events

Antibody Engineering & Therapeutics, San Diego, CA, December 13-17, 2020

Coronavirus (COVID-19) Update: Daily Roundup

China: From Crisis to Recovery

COVID-19 Response

Find out more

Selecting the Right Multiplex Immunoassay Technology

Coronavirus latest: global infections pass 379 million

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Partnership

Become a partner for global business

Solutions For Immunoassays and In Vitro Immunodiagnostics

About

dAb ImmunoTech applies innovative immunoassay technology to focus on developing essential reagents and kits for research and in vitro Diagnostics of cancer and infectious diseases.

dAb ImmunoTech

  • Home
  • Company
  • COVID-19
  • Services
  • Support
  • News
  • Contact

Contact Info

General Inquiries
info@dabimmunotech.com
Business Inquiries
business@dabimmunotech.com
+1-470-556-1748
dAb ImmunoTech Headquarters
11555 Medlock Bridge Road
Johns Creek, GA 30097 USA

Lab & Manufacture Facilities
1860 Montreal Road
Tucker, GA 30084 USA
Copyright © 2025 dAb ImmunoTech. All rights reserved.